                               SEQUENCE LISTING

<110> ANDERSON, DAVID E.
 
<120> COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT
      GLIOMAS

<130> ANDEDAV-3-35608

<140>
<141>

<150> 61/719,681
<151> 2012-10-29

<160> 11    

<170> PatentIn version 3.5

<210> 1
<211> 49
<212> PRT
<213> Homo sapiens

<400> 1
Lys Val Ala Glu Leu Val His Phe Leu Leu Leu Lys Tyr Arg Ala Arg 
1               5                   10                  15      


Glu Pro Val Thr Lys Ala Glu Met Leu Gly Ser Val Val Gly Asn Trp 
            20                  25                  30          


Gln Tyr Phe Phe Pro Val Ile Phe Ser Lys Ala Ser Ser Ser Leu Gln 
        35                  40                  45              


Leu 
    


<210> 2
<211> 25
<212> PRT
<213> Homo sapiens

<400> 2
Leu Leu Arg Phe Trp Leu Pro Phe Gly Phe Ile Leu Ile Leu Val Ile 
1               5                   10                  15      


Phe Val Thr Gln Leu Leu Leu Arg Lys 
            20                  25  


<210> 3
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Lys Val Asp Glu Leu Ala His Phe Leu Leu Arg Lys Tyr Arg Ala Lys 
1               5                   10                  15      


<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Leu Arg Lys Tyr Arg Ala Lys Glu Leu Val Thr Lys Ala Glu Met Leu 
1               5                   10                  15      


<210> 5
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Trp Gln Tyr Phe Phe Pro Val Ile Phe Ser Lys Ala Ser Ser Ser Leu 
1               5                   10                  15      


Gln Leu 
        


<210> 6
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Leu Leu Arg Phe Trp Leu Pro Phe Gly Phe Ile Leu Ile Leu Val 
1               5                   10                  15  


<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Ile Leu Ile Leu Val Ile Phe Val Thr Gln Leu Leu Leu Arg Lys 
1               5                   10                  15  


<210> 8
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Ile Leu Ile Leu Val Ile Phe Val Thr Gly Leu Leu Leu Arg Lys 
1               5                   10                  15  


<210> 9
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Glu Asn Pro Val Val His Phe Phe Lys Asn Ile Val Thr Pro Arg 
1               5                   10                  15  


<210> 10
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Phe Leu Leu Leu Lys Tyr Arg Ala Arg Glu Pro Val Thr Lys Ala Glu 
1               5                   10                  15      


<210> 11
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Phe Phe Pro Val Ile Phe Ser Lys Ala Ser Ser Ser Leu Gln Leu 
1               5                   10                  15  


